Key Financial Data Of Reporting Company

MEDIPAL HOLDINGS CORPORATION - Filing #7298033

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
1,824,672,000,000 JPY
3,558,732,000,000 JPY
1,778,989,000,000 JPY
Ordinary profit (loss)
35,080,000,000 JPY
64,570,000,000 JPY
29,299,000,000 JPY
Net assets
757,655,000,000 JPY
736,612,000,000 JPY
714,616,000,000 JPY
Total assets
1,879,759,000,000 JPY
1,799,127,000,000 JPY
1,815,781,000,000 JPY
Basic earnings (loss) per share
103.94
195.83
80.48
Diluted earnings per share
Equity-to-asset ratio
0.329 xbrli:pure
0.334 xbrli:pure
0.321 xbrli:pure
Net cash provided by (used in) operating activities
41,832,000,000 JPY
61,843,000,000 JPY
31,215,000,000 JPY
Net cash provided by (used in) investing activities
-6,520,000,000 JPY
-7,817,000,000 JPY
-10,800,000,000 JPY
Net cash provided by (used in) financing activities
-14,376,000,000 JPY
-25,248,000,000 JPY
-12,738,000,000 JPY
Cash and cash equivalents
249,016,000,000 JPY
228,084,000,000 JPY
206,983,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.